The global urology devices market is projected to reach USD 64.46 billion by 2032.

From GlobeNewswire: 2025-04-15 09:20:00

The global Urology Devices Market is projected to reach USD 64.46 billion by 2032, growing at a CAGR of 7.35%. The U.S. market alone is expected to expand to USD 29.58 billion by 2032, driven by rising urological disorders and advanced diagnostic technologies. Key players include Boston Scientific, Medtronic, and Siemens Healthineers.

Increasing prevalence of kidney diseases and urological cancers is fueling demand for urology devices worldwide. Market growth is also driven by technological advancements, AI integration in diagnostic imaging, and rising healthcare infrastructure in emerging economies. The market is expected to see continued growth over the next decade due to increased awareness and screening efforts.

In 2023, kidney diseases accounted for over 37% of the total urology devices market share, while hospitals, ASCs, and clinics held 48% of the revenue. The fastest-growing segment is home healthcare, driven by the need for self-catheterization devices. Specialty urology centers are also on the rise, offering customized treatment protocols and specialized care pathways.

North America led the global urology devices market in 2023, with a strong healthcare system and adoption of minimally invasive technologies. Asia Pacific is expected to see the highest growth rate, driven by increasing urological disorders and improved healthcare access. Key regions covered include North America, Europe, Asia Pacific, Middle East & Africa, Latin America.

Overall, the urology devices market is experiencing robust growth due to demographic, technological, and epidemiological trends. With a focus on innovation, advanced technologies, and increasing healthcare investments, the market is set to continue its expansion in the coming years. China, India, and Japan are investing in medical technology and urology infrastructure, leading to long-term market growth. Recent developments include Medtronic’s advanced lithotripsy system, Olympus’s flexible ureteroscope, and Boston Scientific’s single-use ureteroscope. Globally, over 850 million people had kidney disorders in 2023, driving demand for urology interventions. North America led in urological procedures, while Asia Pacific saw a rise in private healthcare spending on urological care. Disposable devices’ demand increased by 18% year-over-year.

Statistics show that globally, the usage of endoscopic and lithotripsy devices is expected to double by 2032, with annual unit shipments projected to exceed 15 million. In 2023, North America allocated nearly 12% of total healthcare expenditure to urology and nephrology, while Asia Pacific saw a 9.5% increase in private healthcare spending on urological care. Hospitals accounted for 60% of all urology device purchases globally, with specialty clinics and ASCs making up 25% and 10%, respectively.

Key points in the market analysis include an introduction, executive summary, research methodology, market dynamics impact analysis, statistical insights and trends reporting, competitive landscape, urology devices market by product, application, and end user, regional analysis, company profiles, and use cases. Related reports cover urinary incontinence treatment devices, Foley catheters, ureteroscopes, and urinary catheters markets. SNS Insider is a leading market research and consulting agency providing current market data for informed decision-making.



Read more at GlobeNewswire: Urology Devices Market Size to Hit USD 64.46 Billion by